Literature DB >> 19655639

A case study of the provision of antiretroviral therapy for refugees in Tanzania.

Hobokela Stephen1, Bayard Roberts.   

Abstract

Tanzania is host to one of the highest refugee populations in the world, with over half a million refugees in 2006. The purpose of this case study was to explore the application of the UNHCR ART policy for the provision of therapeutic, long-term antiretroviral therapy (ART) to refugees in Tanzania. A case study method was used and 18 semistructured key-informants interviews were conducted in July 2007 with a cross-section of stakeholders involved in provision of ART to refugees in Tanzania. The results suggest positive implementation of the key principles of the UNHCR policy. Some differing opinions existed between respondents over the key principles of considering ART provision at earliest possible stage of displacement, and the criteria for repatriation of refugees. The right of refugees to access ART is increasingly accepted and Tanzania provides a positive example of how ART services can be scaled up for refugees.

Mesh:

Substances:

Year:  2009        PMID: 19655639     DOI: 10.1080/13623690902943412

Source DB:  PubMed          Journal:  Med Confl Surviv        ISSN: 1362-3699


  2 in total

1.  Randomized trial of time-limited interruptions of protease inhibitor-based antiretroviral therapy (ART) vs. continuous therapy for HIV-1 infection.

Authors:  Cynthia Firnhaber; Livio Azzoni; Andrea S Foulkes; Robert Gross; Xiangfan Yin; Desiree Van Amsterdam; Doreen Schulze; Deborah K Glencross; Wendy Stevens; Gillian Hunt; Lynn Morris; Lawrence Fox; Ian Sanne; Luis J Montaner
Journal:  PLoS One       Date:  2011-06-28       Impact factor: 3.240

Review 2.  HIV/AIDS health care challenges for cross-country migrants in low- and middle-income countries: a scoping review.

Authors:  Rapeepong Suphanchaimat; Angkana Sommanustweechai; Chiraporn Khitdee; Chompoonut Thaichinda; Kanang Kantamaturapoj; Pattara Leelahavarong; Pensom Jumriangrit; Thitikorn Topothai; Thunthita Wisaijohn; Weerasak Putthasri
Journal:  HIV AIDS (Auckl)       Date:  2014-02-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.